Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reviews|October 12, 2013
The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancerNuria Ribelles, Angela Santonja, Bella Pajares, et al.
Critical Reviews in Oncology/Hematology|January 11, 2012
Targeted therapies in the treatment of germ cell tumors: the need for new approaches against "orphan" tumorsAlfonso Sánchez-Muñoz, Begoña Jiménez-Rodríguez, Víctor Navarro-Pérez, et al.
Oral Oncology|October 3, 2012
Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patientsBegoña Jiménez, José M Trigo, Bella I Pajares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Melanoma: AMBER Cohorts 1c, 1e, and 2ADiwakar Davar, Zeynep Eroglu, Casilda Llácer Pérez, et al.
Frontiers in Oncology|June 7, 2021
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective StudyNicolas Epaillard, Pauline Parent, Yohann Loriot, et al.
Clinical Breast Cancer|January 16, 2013
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic valueAlfonso Sánchez-Muñoz, Yessica Maria Plata-Fernández, Margarita Fernández, et al.
Journal of Clinical Medicine|August 10, 2019
Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer DiagnosisBegona Jimenez Rodriguez, Gema Diaz Córdoba, Alicia Garrido Aranda, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomesAlfonso Sánchez-Muñoz, Luis Vicioso, Angela Santonja, et al.
European Urology Oncology|July 17, 2019
Risk Prediction Tools Available for Germline BRCA1/2 Mutations Underperform in Prostate Cancer PatientsLucía Oliva, Rebeca Lozano, Casilda Llácer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2023
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate CancerDavid Pook, Daniel M Geynisman, Joan Carles, et al.
Pageof 2